Glomerular expression of CD80 and CD86 is required for leukocyte accumulation and injury in crescentic glomerulonephritis

Journal of the American Society of Nephrology

Volumn 16, Issue 7, 2005, Pages 2012-2022

  Odobasic, Dragana ^a   Kitching, A Richard ^a   Semple, Timothy J ^a   Timoshanko, Jennifer R ^a   Tipping, Peter G ^a   Holdsworth, Stephen R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD4 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR; GAMMA INTERFERON; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY; PADGEM PROTEIN; CD86 PROTEIN, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE EXACERBATION; EFFECTOR CELL; GLOMERULONEPHRITIS; GLOMERULUS; GLOMERULUS BASEMENT MEMBRANE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; KIDNEY; KIDNEY INJURY; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; SPLEEN CELL; T LYMPHOCYTE; TH1 CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; IMMUNOLOGY; NEUTROPHIL CHEMOTAXIS; PHYSIOLOGY;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; CHEMOTAXIS, LEUKOCYTE; KIDNEY GLOMERULUS; MACROPHAGES; MALE; MEMBRANE GLYCOPROTEINS; MICE; TH1 CELLS;

EID: 27744444603     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004060437     Document Type: Article

References (49)

1. Tipping PG, Neale T, Holdsworth SR: T lymphocyte participation in antibody-induced experimental glomerulonephritis. Kidney Int 27: 530-537, 1985
2. Huang XR, Tipping PG, Apostolopoulos J, Oettinger C, D'Souza M, Milton G, Holdsworth SR: Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin Exp Immunol 109: 134-142, 1997
3. Huang XR, Holdsworth SR, Tipping PG: Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation. Kidney Int 46: 69-78, 1994
4. Kitching AR, Tipping PG, Huang XR, Mutch D, Holdsworth SR: Interleukin-4 and interleukin-10 attenuate established crescentic glomerulonephritis in mice. Kidney Int 52: 52-59, 1997
5. Kitching AR, Tipping PG, Mutch D, Huang XR, Holdsworth SR: Interleukin-4 deficiency enhances Th1 responses and crescentic glomerulonephritis in mice. Kidney Int 53: 112-118, 1998
6. Li S, Holdsworth SR, Tipping PG: Antibody independent crescentic glomerulonephritis in mu-chain deficient mice. Kidney Int 51: 672-678, 1997
7. Holdsworth SR, Kitching AR, Tipping PG: Th1 and Th2 T helper cell subsets affect patterns of injury and outcomes in glomerulonephritis. Kidney Int 55: 1198-1216, 1999
8. Salomon B, Bluestone JA: Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 19: 225-252, 2001
9. Harding FA, McArthur JG, Gross JA, Raulet DH, Allison JP: CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356: 607-609, 1992
10. Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, Thompson CB, Greisser H, Mak TW: Lymphoproliferative disorders with early lethality in mice deficient in CTLA-4. Science 270: 985-988, 1995
11. Chang T, Jabs C, Sobel RA, Kuchroo VK, Sharpe AH: Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med 190: 733-740, 1999
12. Khoury SJ, Akalin E, Chandraker A, Turka LA, Linsley PS, Sayegh MH, Hancock WW: CD28-B7 costimulatory blockade by CTLA4Ig prevents actively induced experimental autoimmune encephalomyelitis and inhibits Th1 but spares Th2 cytokines in the central nervous system. J Immunol 155: 4521-4524, 1995
13. Webb LM, Walmsley MJ, Feldmann M: Prevention and amelioration of collagen-induced arthritis by blockade of the CD28 co-stimulatory pathway: Requirement for both B7-1 and B7-2. Eur J Immunol 26: 2320-2328, 1996
14. Peterson K, Sharp G, Tang H, Braley-Mullen H: B7.2 has opposing roles during the activation versus effector stages of experimental autoimmune thyroiditis. J Immunol 162: 1859-1867, 1999
15. Karandikar N, Vanderlugt C, Eagar T, Tan L, Bluestone J: Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. J Immunol 161: 192-199, 1998
16. Reynolds J, Tam F, Chandraker A, Smith J, Karkar A, Cross J, Peach R, Sayegh MH, Pusey C: CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis. J Clin Invest 105: 643-651, 2000
17. Nishikawa K, Linsley PS, Collins AB, Stamenkovic I, McCluskey RT, Andres G: Effect of CTLA-4 chimeric protein on rat auto-immune anti-glomerular basement membrane disease. Eur J Immunol 24: 1249-1254, 1994
18. Tada Y, Nagasawa K, Ho A, Morito F, Koarada S, Ushiyama O, Suzuki N, Ohta A, Mak TW: Role of the costimulatory molecule CD28 in the development of lupus in MRL/lpr mice. J Immunol 163: 3153-3159, 1999
19. Liang B, Kashgarian M, Sharpe AH, Mamula M: Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus. J Immunol 165: 3436-3443, 2000
20. Li S, Holdsworth SR, Tipping PG: B7-1 and B7-2 co-stimulatory molecules regulate crescentic glomerulonephritis. Eur J Immunol 30: 1394-1401, 2000
21. Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR: Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Faslpr mice. J Immunol 164: 6046-6056, 2000
22. Azuma H, Chandraker K, Nadeau W, Hancock C: Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci U S A 93: 12439-12444, 1996
23. Chandraker A, Azuma H, Nadeau K, Carpenter C: Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection. J Clin Invest 101: 2309-2318, 1998
24. Wu Q, Jinde K, Endoh M, Sakai H: Costimulatory molecules CD80 and CD86 in human crescentic glomerulonephritis. Am J Kidney Dis 41: 950-961, 2003
25. Tipping PG, Huang XR, Berndt M, Holdsworth SR: P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: Studies in glomerulonephritis and cutaneous delayed-type hypersensitivity. Eur J Immunol 26: 454-460, 1996
26. Tipping PG, Kitching AR, Huang XR, Mutch D, Holdsworth SR: Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Eur J Immunol 27: 530-537, 1997
27. Ruth A, Kitching A, Semple T, Tipping P, Holdsworth S: Intrinsic renal cell expression of CD40 directs Th1 effectors inducing experimental crescentic glomerulonephritis. J Am Soc Nephrol 14: 2813-2822, 2003
28. Kitching AR, Holdsworth SR, Tipping PG: IFN-gamma mediates crescent formation and cell-mediated immune injury in murine glomerulonephritis. J Am Soc Nephrol 10: 752-759, 1999
29. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, Qin HY, Fuchs E, Singh B, Thompson CB, Bluestone JA: CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5: 285-293, 1996
30. Girvin AM, Dal Canto MC, Rhee L, Salomon B, Sharpe AH, Bluestone JA, Miller SD: A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: A comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. J Immunol 164: 136-143, 2000
31. Xu H, Manivannan A, Jiang H-R, Liversidge J: Recruitment of IFN-gamma producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand:P/E-selectin interactions. J Immunol 172: 3215-3224, 2004
32. Austrup F, Vestweber D, Borges E, Lohning M: P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues. Nature 385: 81-83, 1997
33. Mackay I, Rosen F: T-cell function and migration. N Engl J Med 343: 1021-1030, 2000
34. Janssen U, Ostendorf T, Gaertner S, Eitner F: Improved survival and amelioration of nephrotoxic nephritis in intracellular adhesion molecule-1 knockout mice. J Am Soc Nephrol 9: 1805-1814, 1998
35. Timoshanko J, Sedgwick J, Holdsworth S, Tipping P: Intrinsic renal cells are the major source of tumour necrosis factor contributing to renal injury in murine crescentic glomerulonephritis. J Am Soc Nephrol 14: 1785-1793, 2003
36. Ogawa D, Shikata K, Matsuda M, Okada S: Preventive effect of sulphated colominic acid on P-selectin-dependent infiltration of macrophages in experimentally induced crescentic glomerulonephritis. Clin Exp Immunol 129: 43-53, 2002
37. Abrams J, Kelley S, Hayes E, Kikuchi T: Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells and endothelial cells. J Exp Med 192: 681-693, 2000
38. Lan H, Bacher M, Yang N, Mu W: The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med 185: 1455-1465, 1997
39. Yang N, Nikolic-Patterson D, Ng Y, Mu W: Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): Potential role of MIF in regulating glucocorticoid production. Mol Med 4: 413-424, 1998
40. Timoshanko J, Kitching A, Iwakura Y, Holdsworth S, Tipping P: Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol 15: 910-918, 2004
41. Timoshanko J, Holdsworth S, Kitching A, Tipping P: IFN-gamma production by intrinsic renal cells and bone-marrow derived cells is required for full expression of crescentic glomerulonephritis in mice. J Immunol 168: 4135-4141, 2002
42. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TNC, Salant DJ, Gutierrez-Ramos J-C: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185: 1371-1380, 1997
43. Natori Y, Sekiguchi Z: Gene expression of CC chemokines in experimental crescentic glomerulonephritis (CGN). Clin Exp Immunol 109: 143-148, 1997
44. Schadde E, Kretzler M, Banas B, Luckow B: Expression of chemokines and their receptors in nephrotoxic serum nephritis. Nephrol Dial Transplant 15: 1046-1053, 2000
45. Banas B, Wenzel U, Stahl R, Schlondorff D: Role of chemokines in glomerular diseases. Kidney Blood Press Res 19: 270-280, 1996
46. Herold KC, Lu J, Rulifson IC, Vezys V, Taub D, Grusby MJ, Bluestone JA: Regulation of C-C chemokine production by murine T cells by CD28/B7 costimulation. J Immunol 159: 4150-4153, 1997
47. Carroll R, Riley J, Levine B, Feng Y: Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells. Science 276: 273-276, 1997
48. Frangogiannis N, Mondoza L, Smith C, Michael L, Entman M: Induction of the synthesis of the C-X-C chemokine interferon-gamma-inducible protein-10 in experimental canine endotoxemia. Cell Tiss Res 302: 365-376, 2000
49. Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N: Apoptosis in progressive crescentic glomerulonephritis. Lab Invest 74: 941-951, 1996